Minimal hepatic encephalopathy characterized by parallel use of the continuous reaction time and portosystemic encephalopathy tests

Metabolic Brain Disease

Volumn 30, Issue 5, 2015, Pages 1187-1192

  Lauridsen, M M ^a,b   Schaffalitzky de Muckadell, O B ^b   Vilstrup, H ^c  

^a Hospital of South West Jutland ^*  (Denmark)

^b ODENSE UNIVERSITY HOSPITAL   (Denmark)

^c AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Hepatic encephalopathy; Liver cirrhosis; Portosystemic encephalopathy test; Psychometric test; Reaction time

Indexed keywords

AMMONIA; C REACTIVE PROTEIN;

ADULT; ARTICLE; AUDITORY RESPONSE; CLINICAL EVALUATION; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTINUOUS REACTION TIME; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEPATIC ENCEPHALOPATHY; HIGH RISK PATIENT; HUMAN; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MINIMAL HEPATIC ENCEPHALOPATHY; MORTALITY; NEUROPSYCHOLOGICAL TEST; PORTOSYSTEMIC ENCEPHALOPATHY TEST; PSYCHOMETRY; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; REACTION TIME; RESPONSE TIME; RISK ASSESSMENT; RISK FACTOR; AGED; AUDITORY STIMULATION; CLINICAL TRIAL; MULTICENTER STUDY; PHYSIOLOGY; PROCEDURES; PROSPECTIVE STUDY; PSYCHOLOGY; PSYCHOMOTOR PERFORMANCE;

ACOUSTIC STIMULATION; ADULT; AGED; FEMALE; HEPATIC ENCEPHALOPATHY; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PROSPECTIVE STUDIES; PSYCHOMETRICS; PSYCHOMOTOR PERFORMANCE; REACTION TIME;

EID: 84941176564     PISSN: 08857490     EISSN: 15737365     Source Type: Journal    
DOI: 10.1007/s11011-015-9688-7     Document Type: Article

References (31)

1. Arguedas MR, DeLawrence TG, McGuire BM (2003) Influence of hepatic encephalopathy on health-related quality of life in patients with cirrhosis. Dig Dis Sci 48(8):1622–1626
2. Bajaj JS (2008) Minimal hepatic encephalopathy matters in daily life. World J Gastroenterol 14(23):3609–3615
3. Bajaj JS, Saeian K, Schubert CM, Hafeezullah M, Franco J, Varma RR et al (2009) Minimal hepatic encephalopathy is associated with motor vehicle crashes: the reality beyond the driving test. Hepatology 50(4):1175–1183
4. Bajaj JS, Wade JB, Gibson DP, Heuman DM, Thacker LR, Sterling RK et al (2011a) The multi-dimensional burden of cirrhosis and hepatic encephalopathy on patients and caregivers. Am J Gastroenterol 106(9):1646–1653
5. Bajaj JS, Heuman DM, Wade JB, Gibson DP, Saeian K, Wegelin JA et al (2011b) Rifaximin improves driving simulator performance in a randomized trial of patients with minimal hepatic encephalopathy. Gastroenterology 140(2):478–87.e1
6. Bajaj JS, Heuman DM, Sterling RK, Sanyal AJ, Siddiqui M, Matherly S et al (2014) Validation of EncephalApp, smartphone-based stroop test, for the diagnosis of covert hepatic encephalopathy. Clin Gastroenterol Hepatol
7. Elsass P (1986) Continuous reaction times in cerebral dysfunction. Acta Neurol Scand 73:225–246
8. Elsass P, Christensen SE, Mortensen EL, Vilstrup H (1985) Discrimination between organic and hepatic encephalopathy by means of continuous reaction times. Liver 5(1):29–34
9. Goldbecker A, Weissenborn K, Hamidi Shahrezaei G, Afshar K, Rumke S, Barg-Hock H et al (2013) Comparison of the most favoured methods for the diagnosis of hepatic encephalopathy in liver transplantation candidates. Gut 62(10):1497–1504
10. Groeneweg M, Quero JC, De Bruijn I, Hartmann IJ, Essink-bot ML, Hop WC et al (1998) Subclinical hepatic encephalopathy impairs daily functioning. Hepatology 28(1):45–49
11. Jakobsen LH, Sorensen JM, Rask IK, Jensen BS, Kondrup J (2010) Validation of reaction time as a measure of cognitive function and quality of life in healthy subjects and patients. Nutrition
12. Jepsen P, Vilstrup H, Andersen PK, Lash TL, Sorensen HT (2008) Comorbidity and survival of Danish cirrhosis patients: a nationwide population-based cohort study. Hepatology 48(1):214–220
13. Kato A, Kato M, Ishii H, Ichimiya Y, Suzuki K, Kawasaki H et al (2004) Development of quantitative neuropsychological tests for diagnosis of subclinical hepatic encephalopathy in liver cirrhosis patients and establishment of diagnostic criteria-multicenter collaborative study in Japanese. Hepatol Res Off J Jpn Soc Hepatol 30(2):71–78
14. Lauridsen MM, Jepsen P, Vilstrup H (2011) Critical flicker frequency and continuous reaction times for the diagnosis of minimal hepatic encephalopathy: a comparative study of 154 patients with liver disease. Metab Brain Dis 26(2):135–139
15. Lauridsen MM, Gronbaek H, Naeser EB, Leth ST, Vilstrup H (2012) Gender and age effects on the continuous reaction times method in volunteers and patients with cirrhosis. Metab Brain Dis
16. Lauridsen MM, Thiele M, Kimer N, Vilstrup H (2013) The continuous reaction times method for diagnosing, grading, and monitoring minimal/covert hepatic encephalopathy. Metab Brain Dis
17. Lauridsen MM, Frojk J, de Muckadell OB, Vilstrup H (2014) Opposite effects of sleep deprivation on the continuous reaction times in patients with liver cirrhosis and normal persons. Metab Brain Dis 29(3):655–660
18. Li SW, Wang K, Yu YQ, Wang HB, Li YH, Xu JM (2013) Psychometric hepatic encephalopathy score for diagnosis of minimal hepatic encephalopathy in China. World J Gastroenterol 19(46):8745–8751
19. Maldonado-Garza HJ, Vazquez-Elizondo G, Gaytan-Torres JO, Flores-Rendon AR, Cardenas-Sandoval MG, Bosques-Padilla FJ (2011) Prevalence of minimal hepatic encephalopathy in cirrhotic patients. Ann Hepatol 10(Suppl 2):S40–S44
20. Montagnese S, Biancardi A, Schiff S, Carraro P, Carla V, Mannaioni G et al (2011) Different biochemical correlates for different neuropsychiatric abnormalities in patients with cirrhosis. Hepatology 53(2):558–566
21. Nabi E, Thacker LR, Wade JB, Sterling RK, Stravitz RT, Fuchs M et al (2014) Diagnosis of covert hepatic encephalopathy without specialized tests. Clin Gastroenterol Hepatol 12(8):384–9.e2
22. Ortiz M, Jacas C, Cordoba J (2005) Minimal hepatic encephalopathy: diagnosis, clinical significance and recommendations. J Hepatol 42(Suppl 1):S45–S53
23. Patidar KR, Thacker LR, Wade JB, Sterling RK, Sanyal AJ, Siddiqui MS et al (2014) Covert hepatic encephalopathy is independently associated with poor survival and increased risk of hospitalization. Am J Gastroenterol
24. Prasad S, Dhiman RK, Duseja A, Chawla YK, Sharma A, Agarwal R (2007) Lactulose improves cognitive functions and health-related quality of life in patients with cirrhosis who have minimal hepatic encephalopathy. Hepatology 45(3):549–559
25. Schomerus H, Hamster W (2001) Quality of life in cirrhotics with minimal hepatic encephalopathy. Metab Brain Dis 16(1–2):37–41
26. Sharma P, Sharma BC, Sarin SK (2010) Critical flicker frequency for diagnosis and assessment of recovery from minimal hepatic encephalopathy in patients with cirrhosis. Hepatobiliary Pancreat Dis Int 9(1):27–32
27. Shawcross DL, Davies NA, Williams R, Jalan R (2004) Systemic inflammatory response exacerbates the neuropsychological effects of induced hyperammonemia in cirrhosis. J Hepatol 40(2):247–254
28. Sidhu SS, Goyal O, Mishra BP, Sood A, Chhina RS, Soni RK (2011) Rifaximin improves psychometric performance and health-related quality of life in patients with minimal hepatic encephalopathy (the RIME Trial). Am J Gastroenterol 106(2):307–316
29. Sturgeon JP, Shawcross DL (2014) Recent insights into the pathogenesis of hepatic encephalopathy and treatments. Exp Rev Gastroenterol Hepatol 8(1):83–100
30. Vilstrup H, Amodio P, Bajaj J, Cordoba J, Ferenci P, Mullen KD et al (2014) Hepatic encephalopathy in chronic liver disease: 2014 practice guideline by the american association for the study of liver diseases and the european association for the study of the liver. Hepatology 60(2):715–735
31. Weissenborn K (2012) Psychometric tests for diagnosing minimal hepatic encephalopathy. Metab Brain Dis